Eureka Biotech Call 2026
Health Holland has allocated €1.5 million Public Private Partnership (PPP) subsidy, and invites companies and research organisations to participate in the EUREKA Biotech Call. This international call offers opportunities for innovative R&D collaborations with partners from multiple countries, aimed at accelerating biotechnological innovations with societal and economic impact. In this call, the Netherlands specifically focuses on advancing innovative cell and gene therapies (CGT) and Organ-on-Chip (OoC) technologies, with the goal of accelerating the translation of research into practical applications, thereby contributing to the economic earning capacity and international position of the Netherlands.
Why participate?
The EUREKA Biotech Call offers Dutch organisations the opportunity to take the next step in the development of innovative CGT and OoC solutions through international collaboration. Both Dutch SMEs and Dutch research organisations are eligible to apply for PPS subsidy.
Participation in this call provides access to an international network of companies and research organisations. These strategic partnerships and the exchange of knowledge enable participants to advance the translation of research into practical solutions, thereby creating both economic and societal value for all participating countries.
Who can apply?
A consortium must consist of at least two independent Dutch partners, complemented by at least two independent partners from one of the priority countries participating in this EUREKA Call. For both the Netherlands and the priority countries, at least one company and one research organisation must be involved. The partners jointly carry out R&D within a balanced consortium that delivers value for all participating countries.
Health Holland priority countries that also participate in this EUREKA Biotech Call are Belgium, France, Germany, Singapore, Spain, Sweden, and Switzerland. In addition, organisations from other countries may participate, provided they secure their own funding.
Funding available
Per project, a minimum of €400.000,- and a maximum of €750.000,- PPP subsidy is available for participating Dutch partners.
- Dutch research organisations and Dutch SMEs may receive PPP subsidy covering a percentage of their eligible project costs, subject to the applicable financial conditions.
- Other types of organisations, such as healthcare providers and foundations, are not eligible for PPS subsidy.
- International partners are responsible for securing their own funding.
- Cash contributions are permitted but not mandatory. A single party may not both receive PPP subsidy and provide a cash contribution to the project
Key eligibility requirements
- The consortium consists of at least one Dutch company, one Dutch research organisation, and both a company and a research organisation from one of the participating priority countries.
- Dutch companies applying for PPP subsidy must submit a “No Undertaking in Difficulty” declaration at the time of application, including the relevant decision tree and, where applicable, an organisational chart of the affiliated group.
- The use of the consortium agreement template provided for this call is mandatory, including the provisions regarding intellectual property. Only minimal modifications are permitted.
- The project must consist of industrial research and/or experimental development (TRL 4-7).
- Co-funding by all partners (in-kind and, where applicable, in cash) is required.
Application procedure and timeline
|
⚠️ Please note: Dutch consortia applying for funding from Health Holland are strongly encouraged to announce their participation in advance by contacting RVO and Health Holland prior to submission.
|
The application procedure consists of a central submission via the online EUREKA project application form, supplemented by national documentation for Dutch participants. The deadline is 25 September 2026. The required national documentation can be found below. An additional document outlining the applicable conditions in detail is also available below.
For questions, please reach out to:
RVO Call management: Niels van Leeuwen – niels.vanleeuwen@rvo.nl or teamiris@rvo.nl
Health Holland Call management: Jolande Zijlstra, Annebel Hendrix, Daan Dolfing – tki@health-holland.com